Photo Credit: Pikovit44
The following is a summary of “Application of new type ureteroscope and traditional linear ureteroscope in ureteric stone patients,” published in the December 2024 issue of Urology by Tong et al.
Ureteric stones are found in the ureter and are often treated with conservative methods or minimally invasive surgery, which can cause significant pain. A new ureteroscope shows promise in improving treatment outcomes for these patients.
Researchers conducted a retrospective study to explore the clinical application of a new ureteroscope for treating ureteric stones.
They recruited 120 patients with ureteric stones from January 1, 2023, to December 31, 2023, randomly assigning them to either the control group (traditional ureteroscope) or the experimental group (new ureteroscope). Both groups provided general data and blood samples, and logistic regression analysis was conducted to assess factors influencing postoperative infection, including preoperative CRP > 8 mg/L, postoperative CRP > 8 mg/L, preoperative white blood cell count > 109/L, postoperative white blood cell count > 109/L, preoperative urinalysis count > 28/µL, postoperative urinalysis count > 28/µL, and urine leukocyte count.
The results showed no significant differences in preoperative demographic data (P > 0.05). Postoperative CRP > 8 mg/L, white blood cell count > 10 × 109/L, urinalysis count > 28/µL, and urine leukocyte count were significantly lower in the experimental group (P < 0.05). Binary logistic regression identified postoperative CRP > 8 mg/L (OR = 7.03), white blood cell count > 109/L (OR = 3.86), urinalysis count > 28/µL (OR = 2.83), and urine leukocyte count (OR = 1.004) as predictive factors for ureteric stones. Preoperative values showed no significant difference (P > 0.05).
Investigators found that the new ureteroscope offered significant advantages over traditional ones, including improved surgical operability and reduced risk of postoperative infections. These findings highlighted its potential for broader clinical application and further promotion.
Source: bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01678-3